Brief: Cytek Biosciences Inc Files For Non- Timely 10-K With The U.S. SEC
01/03/2024 21:14
March 1 (Reuters) - Cytek Biosciences Inc CTKB.O :
* CYTEK BIOSCIENCES INC FILES FOR NON- TIMELY 10-K WITH THE
U.S.
SEC
* CYTEK BIOSCIENCES: SEES TO REPORT UNREMEDIATED MATERIAL
WEAKNESSES IN FORM 10-K, FOR QUARTER ENDED SEPT 30, 2023
Further company coverage: CTKB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million